The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro.
Krusch M, Salih J, Schlicke M, Baessler T, Kampa-Schittenhelm K, Mayer F, Salih H. The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro. J Immunol 2009; 183:8286-94.
15.12.2009
The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro.
15.12.2009
J Immunol 2009; 183:8286-94
Krusch Matthias, Salih Julia, Schlicke Manuela, Baessler Tina, Kampa-Schittenhelm Kerstin, Mayer Frank, Salih Helmut Rainer
Weiter
